Search Results - "Bank, J.R."

A steroid-free regime with Alemtuzumab induction significantly reduced acute rejection rate in simultaneous pancreas kidney transplant recipients by Bank, J.R, Mallat, M.J.K, van de Boog, P.J.M, Braat, A.E, Ringers, J, Reinders, M.E.J, de Fijter, J.W

Get full text

Urinary metabolites predict prolonged duration of delayed graft function in DCD kidney transplant recipients by Kostidis, S., Bank, J. R., Soonawala, D., Nevedomskaya, E., Kooten, C., Mayboroda, O. A., Fijter, J. W.

“…Extending kidney donor criteria, including donation after circulatory death (DCD), has resulted in increased rates of delayed graft function (DGF) and primary…”
Get full text

Presence of CD163+ macrophages in DCD kidneys with high DGF reduces the risk for acute cellular rejection in 6 months after kidney transplantation by van Alem, C.M.A., Bank, J.R., de Vries, D.K., Bajema, I.M., Mallat, M.J.K., de Fijter, J.W., Rotmans, J.I., van Kooten, C.

“…Acute cellular rejection (ACR) occurs in 10% of renal allograft recipients and is characterized by leukocyte infiltration as observed in needle biopsies. ACR…”
Get full text

Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients by Reinders, M. E. J., de Fijter, J. W., Rabelink, T. J., Bank, J. R.

“…Despite excellent short-term graft survival after renal transplantation, the long-term graft outcome remains compromised. It has become evident that a…”
Get full text